WallStreetZenWallStreetZen

NASDAQ: EDSA
Edesa Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EDSA

Based on 1 analyst offering 12 month price targets for Edesa Biotech Inc

Min Forecast
$5.00+525%
Avg Forecast
$5.00+525%
Max Forecast
$5.00+525%

Should I buy or sell EDSA stock?

Based on 1 analyst offering ratings for Edesa Biotech Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EDSA stock forecasts and price targets.

EDSA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-03

1 of 1

Forecast return on equity

Is EDSA forecast to generate an efficient return?

Company
-83.29%
Industry
206.41%
Market
259.47%
EDSA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EDSA forecast to generate an efficient return on assets?

Company
-79.01%
Industry
93%
EDSA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EDSA earnings per share forecast

What is EDSA's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.82
Avg 2 year Forecast
-$1.88
Avg 3 year Forecast
-$1.39

EDSA revenue forecast

What is EDSA's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

EDSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EDSA$0.80$5.00+525.00%Buy
DWTX$2.93$12.00+309.56%Buy
AIXC$1.24N/AN/A
CLGN$0.62$12.00+1,848.05%Strong Buy
APVO$6.66N/AN/A
View Top Biotech Stocks

Edesa Biotech Stock Forecast FAQ

Is Edesa Biotech Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EDSA) stock is to Buy EDSA stock.

Out of 1 analyst, 0 (0%) are recommending EDSA as a Strong Buy, 1 (100%) are recommending EDSA as a Buy, 0 (0%) are recommending EDSA as a Hold, 0 (0%) are recommending EDSA as a Sell, and 0 (0%) are recommending EDSA as a Strong Sell.

If you're new to stock investing, here's how to buy Edesa Biotech stock.

What is EDSA's earnings growth forecast for 2026-2028?

(NASDAQ: EDSA) Edesa Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 120.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 113.78%.

Edesa Biotech's earnings in 2026 is -$7,815,939.On average, 5 Wall Street analysts forecast EDSA's earnings for 2026 to be -$15,213,689, with the lowest EDSA earnings forecast at -$26,670,705, and the highest EDSA earnings forecast at -$8,239,635. On average, 4 Wall Street analysts forecast EDSA's earnings for 2027 to be -$15,667,829, with the lowest EDSA earnings forecast at -$24,461,781, and the highest EDSA earnings forecast at -$6,048,243.

In 2028, EDSA is forecast to generate -$11,623,145 in earnings, with the lowest earnings forecast at -$17,835,011 and the highest earnings forecast at -$4,821,063.

What is EDSA's revenue growth forecast for 2026-2028?

(NASDAQ: EDSA) Edesa Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 323.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 66.01%.

Edesa Biotech's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast EDSA's revenue for 2026 to be $0, with the lowest EDSA revenue forecast at $0, and the highest EDSA revenue forecast at $0. On average, 5 Wall Street analysts forecast EDSA's revenue for 2027 to be $0, with the lowest EDSA revenue forecast at $0, and the highest EDSA revenue forecast at $0.

In 2028, EDSA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is EDSA's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: EDSA) forecast ROA is -79.01%, which is lower than the forecast US Biotechnology industry average of 93%.

What is EDSA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EDSA price target, the average EDSA price target is $5.00, with the highest EDSA stock price forecast at $5.00 and the lowest EDSA stock price forecast at $5.00.

The Wall Street analyst predicted that Edesa Biotech's share price could reach $5.00 by Nov 3, 2026. The average Edesa Biotech stock price prediction forecasts a potential upside of 525% from the current EDSA share price of $0.80.

What is EDSA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: EDSA) Edesa Biotech's current Earnings Per Share (EPS) is -$1.15. On average, analysts forecast that EDSA's EPS will be -$1.82 for 2026, with the lowest EPS forecast at -$3.19, and the highest EPS forecast at -$0.99. On average, analysts forecast that EDSA's EPS will be -$1.88 for 2027, with the lowest EPS forecast at -$2.93, and the highest EPS forecast at -$0.72. In 2028, EDSA's EPS is forecast to hit -$1.39 (min: -$2.14, max: -$0.58).

What is EDSA's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: EDSA) forecast ROE is -83.29%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.